Listed

Virgin Galactic Holdings, Inc: Form 10-Q for the period ended Mar 31, 2023

Filed with the SEC on May 9, 2023 and accepted by EDGAR at May 9, 2023, 16:16 ET.

Share

Management's discussion and analysis

As filed, 22,773 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Unless the context otherwise requires, all references in this section to the “Company,” "Virgin Galactic," “we,” “us,” or “our” refer to Virgin Galactic Holdings, Inc. and its subsidiaries.

You should read the following discussion and analysis of our financial condition and results of operations together with the condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q, as well as the audited financial statements and the related notes thereto, and the discussion under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the "Annual Report on Form 10-K"). This discussion contains forward-looking statements that reflect our plans, estimates, and beliefs that involve risks and uncertainties. As a result of many factors, such as those set forth under the “Risk Factors” section of our Annual Report on Form 10-K and under the "Cautionary Note Regarding Forward-Looking Statements" section and elsewhere in this Quarterly Report on Form 10-Q, our actual results may differ materially from those anticipated in these forward-looking statements.

Overview

Virgin Galactic Holdings, Inc. is an aerospace and space travel company offering access to space for private individuals, researchers and government agencies. Our missions include flying passengers to space as tourists, as well as flying scientific payloads and researchers to space in order to conduct experiments for scientific and educational purposes. Our operations include the design and development, manufacturing, ground and flight testing, and post-flight maintenance of our spaceflight system vehicles. Our spaceflight system is developed using our proprietary technology and processes and is focused on providing space experiences for private astronauts, researcher flights and professional astronaut training. We have also leveraged our knowledge and expertise in manufacturing spaceships to occasionally perform engineering services for third parties, such as research, design, development, manufacturing and integration of advanced technology systems.

Factors Affecting Our Performance

We believe that our performance and future success depend on a number of factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in Part 1, Item 1A. of our Annual Report on Form 10-K titled “Risk Factors.”

Commercial Launch of Our Human Spaceflight Program

We are the first spaceline to receive Federal Aviation Administration approval to carry commercial customers to space. This was through an update to our existing commercial spaceflight license which we have held since 2016. We are in the final phases of developing our commercial spaceflight program. Prior to launch of commercial service, we must complete a period of planned maintenance and enhancements to the vehicles, as well as subsequent vehicle flight testing. Commercial service is currently expected to commence in the second quarter of 2023. We continuously monitor our supply chain for potential risk associated with the delivery of materials from our suppliers, which in turn could impact the schedule for completion of the enhancement period and the start of commercial service. We have identified some areas of risk for timely delivery and continue to work on mitigating these identified risks. Any delays in successful completion of our test flight program, whether due to supply chain issues, general macroeconomic factors or otherwise, will impact our ability to generate revenue from human spaceflight.

Customer Demand

While not yet in commercial service for human spaceflight, we have already received significant interest from potential future astronauts. Going forward, we expect the size of our backlog and the number of future astronauts that have flown to space on our spaceflight system to be an important indicator of our future performance. As of March 31, 2023, we had reservations for space flights for approximately 800 future astronauts. In August 2021, following Sir Richard Branson's successful test flight, we reopened ticket sales to a select group and increased the pricing of our consumer offerings to a base price of $450,000 per seat. In February 2022, we opened ticket sales to the general public. We are reserving our first 100 seats within our first 1,000 commercial seats sold for research and scientific experiments. As of March 31, 2023, the tickets sold represent approximately $211 million in expected future spaceflight revenue upon completion of space flights.

Available Capacity and Annual Flight Rate

We expect to commence commercial operations with a single spaceship, VSS Unity, and a single mothership carrier aircraft, VMS Eve, which together comprise our only spaceflight system. As a result, our annual flight rate will be constrained by the availability and capacity of this spaceflight system. Additionally, we may commence commercial operations while temporarily assigning one of the four passenger seats in VSS Unity to be occupied by one of our employees to gather input about the experience in order to help us create a better experience for our customers in the long-term. To reduce the capacity constraint associated with having only one spaceflight system, we are currently developing our next generation spaceflight vehicles, which include our Delta class spaceships and our next generation motherships, which will allow us to increase our annual flight rate. We believe that expanding the fleet will allow us to increase our annual flight rate once commercialization is achieved. We are dedicating significant engineering resources to the work that precedes production of the future fleet. Simultaneously, we are focused on the launch and flight consistency of Unity and Eve to begin bringing our customers to space and to demonstrate the value of our product.

Safety Performance of Our Spaceflight Systems

Our spaceflight systems are highly specialized with sophisticated and complex technology. We have built operational processes to ensure that the design, manufacture, performance and servicing of our spaceflight systems meet rigorous quality standards. However, our spaceflight systems are still subject to operational and process risks, such as manufacturing and design issues, human errors, or cyber-attacks. Any actual or perceived safety issues may result in significant reputational harm to our business and our ability to generate human spaceflight revenue.

Results of Operations

The following tables set forth our results of operations for the periods presented. The period-to-period comparisons of financial results is not necessarily indicative of future results.

(In thousands)

Three Months Ended March 31, 2023 2022
Revenue $392 $319
Operating expenses:
Customer experience 318 25
Selling, general and administrative 50,365 37,007
Research and development 109,870 51,827
Depreciation and amortization 3,245 2,852
Total operating expenses 163,798 91,711
Operating loss (163,406) (91,392)
Interest income 7,330 818
Interest expense (3,211) (2,474)
Other income, net 30 16
Loss before income taxes (159,257) (93,032)
Income tax expense 128 25
Net loss $(159,385) $(93,057)

18

For the Three Months Ended March 31, 2023 Compared to the Three Months Ended March 31, 2022

Revenue

(In thousands, except %)

Three Months Ended March 31, 2023 2022 $ Change % Change
Revenue $392 $319 $73 23%

Revenue for the three months ended March 31, 2023 was primarily attributable to membership fees related to our Future Astronaut community. Revenue for the three months ended March 31, 2022 was primarily attributable to membership fees related to our Future Astronaut community as well as the performance of engineering services.

Customer Experience

(In thousands, except %)

Three Months Ended March 31, 2023 2022 $ Change % Change
Customer experience $318 $25 $293 1,172%

Customer experience costs for the three months ended March 31, 2023 were primarily attributable to costs related to our Future Astronaut community. Customer experience costs for the three months ended March 31, 2022 were primarily attributable to the performance of engineering services.

Selling, General and Administrative

(In thousands, except %)

Three Months Ended March 31, 2023 2022 $ Change % Change
Selling, general and administrative $50,365 $37,007 $13,358 36%

Selling, general and administrative expenses increased from $37.0 million for the three months ended March 31, 2022 to $50.4 million for the three months ended March 31, 2023. The increase was primarily driven by a $7.6 million increase in compensation and other employee benefit costs, a $2.6 million increase in stock-based compensation, a $1.1 million increase in information technology and software costs and a $1.0 million increase in legal and other professional costs.

Research and Development

(In thousands, except %)

Three Months Ended March 31, 2023 2022 $ Change % Change
Research and development $109,870 $51,827 $58,043 112%

Research and development expenses increased from $51.8 million for the three months ended March 31, 2022 to $109.9 million for the three months ended March 31, 2023. The increase was primarily driven by a $42.4 million increase in contract and sub-contract labor, material costs and other direct costs, and a $13.5 million increase in compensation and other employee benefit costs.

Depreciation and Amortization

(In thousands, except %)

Three Months Ended March 31, 2023 2022 $ Change % Change
Depreciation and amortization $3,245 $2,852 $393 14%

Depreciation and amortization expense increased from $2.9 million for the three months ended March 31, 2022 to $3.2 million for the three months ended March 31, 2023, an increase of $0.4 million due to the acquisition of property, plant and equipment.

Interest Income

(In thousands, except %)

Three Months Ended March 31, 2023 2022 $ Change % Change
Interest income $7,330 $818 $6,512 796%

Interest income increased from $0.8 million for the three months ended March 31, 2022 to $7.3 million for the three months ended March 31, 2023. This increase was primarily driven by higher interest rates on marketable securities and deposits in interest bearing accounts.

Interest Expense

(In thousands, except %)

Three Months Ended March 31, 2023 2022 $ Change % Change
Interest expense $3,211 $2,474 $737 30%

Interest expense increased from $2.5 million for three months ended March 31, 2022 to $3.2 million for the three months ended March 31, 2023. This increase was primarily driven by a full quarter of interest expense and amortization of debt issuance costs related to our convertible senior notes.

Income Tax Expense

(In thousands, except %)

Three Months Ended March 31, 2023 2022 $ Change % Change
Income tax expense $128 $25 $103 412%

Income tax expense was immaterial for the three months ended March 31, 2023 and 2022. We have accumulated net operating losses at the U.S. federal and state levels, as we have not yet started commercial operations. We maintain a full valuation allowance against our net U.S. federal and state deferred tax assets. The income tax expense is primarily related to corporate income taxes for our operations in the United Kingdom, which operates on a cost-plus arrangement.

Liquidity and Capital Resources

As of March 31, 2023, we had cash, cash equivalents and restricted cash of $456.1 million and marketable securities of $417.9 million. Our principal sources of liquidity have come from sales of our common stock and offering of convertible senior notes ("2027 Notes").

Historical Cash Flows

(In thousands)

Net cash provided by (used in): Three Months Ended March 31, 2023 2022
Operating activities $(136,069) $(66,051)
Investing activities 219,737 (206,671)
Financing activities 29,795 359,517
Net increase in cash, cash equivalents and restricted cash $113,463 $86,795

20

Operating Activities

Net cash used in operating activities was $136.1 million for the three months ended March 31, 2023, and consisted primarily of $159.4 million of net losses, adjusted for non-cash items, which primarily included stock-based compensation expense of $13.0 million and depreciation and amortization expense of $3.2 million, as well as $6.8 million of cash provided from changes in working capital.

Net cash used in operating activities was $66.1 million for the three months ended March 31, 2022, and consisted primarily of $93.1 million of net losses, adjusted for non-cash items, which primarily included stock-based compensation expense of $10.9 million and depreciation and amortization expense of $2.9 million, as well as $12.8 million of cash provided from changes in working capital.

Investing Activities

Net cash provided by investing activities was $219.7 million for the three months ended March 31, 2023, and consisted of $305.8 million in proceeds from maturities and calls of marketable securities, partially offset by $83.3 million in purchases of marketable securities and $2.8 million in capital expenditures.

Net cash used in investing activities was $206.7 million for the three months ended March 31, 2022, and consisted of $204.9 million in purchases of marketable securities and $1.8 million in capital expenditures.

Financing Activities

Net cash provided by financing activities was $29.8 million for the three months ended March 31, 2023, and consisted primarily of net cash proceeds from the sale and issuance of common stock of $31.7 million, partially offset by tax withholdings paid for net settled stock-based awards of $1.9 million.

Net cash provided by financing activities was $359.5 million for the three months ended March 31, 2022, and consisted primarily of the issuance of the 2027 Notes for net proceeds of $413.8 million, partially offset by the purchase of the capped call related to the 2027 Notes of $52.3 million and tax withholdings paid for net settled stock-based awards of $1.9 million.

Funding Requirements

We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we continue to advance the development of our spaceflight system and the commercialization of our human spaceflight operations. In addition, we expect our operating expenses to increase significantly as we commence commercial operations and add additional spaceships to our operating fleet.

Specifically, our operating expenses will increase as we:

  • scale up our manufacturing processes and capabilities to support expanding our fleet with additional spaceships, carrier aircraft and rocket motors upon commercialization;
  • pursue further research and development on our future human spaceflights, including those related to our research and education efforts on point-to-point travel;
  • hire additional personnel in research and development, manufacturing operations, testing programs, maintenance operations and guest services as we increase the volume of our spaceflights upon commercialization;
  • seek regulatory approval for any changes, upgrades or improvements to our spaceflight technologies and operations in the future, especially upon commercialization;
  • maintain, expand and protect our intellectual property portfolio;
  • establish our astronaut campus in New Mexico; and
  • hire additional personnel in management to support the expansion of our operational, financial, information technology, and other areas to support our operations as a public company.

We expect our arrangements with third-party providers, including under our Master Agreements with Aurora Flight Sciences Corporation (“Aurora"), a wholly owned subsidiary of The Boeing Company, for the design and manufacture of our next generation of carrier aircraft and Bell Textron Inc. ("Bell") and Qarbon Aerospace ("Qarbon") to manufacture key subassemblies for our next generation spaceships, will require significant capital expenditures from us. Certain estimated amounts in connection with third-party arrangements are subject to future negotiations and cannot be estimated with reasonable certainty. Although we believe that our current capital is adequate to sustain our operations for at least the next twelve months, changing circumstances may cause us to consume capital significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control. Additionally, we are in the final phases of developing our commercial spaceflight program. While we anticipate initial commercial launch with a single spaceship, we currently have additional spaceship vehicles under construction. We anticipate the costs to manufacture additional vehicles will begin to decrease as we continue to scale up our manufacturing processes and capabilities. Until we achieve technological feasibility with our spaceflight systems, we will not capitalize expenditures incurred to construct any additional components of our spaceflight systems and we will continue to expense these costs as incurred to research and development.

Issuances of Common Stock

On August 4, 2022, we entered into a distribution agency agreement with Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC (each, an “Agent” and collectively, the “Agents”) providing for the offer and sale of up to $300 million of shares of our common stock from time to time through the Agents, acting as sales agents, or directly to one or more of the Agents, acting as principal, through an "at the market offering" program (the "2022 ATM program").

Since inception and through March 31, 2023, we sold a total of 22.0 million shares of common stock under the 2022 ATM program, generating $135.4 million in gross proceeds, before deducting $1.4 million in underwriting discounts, commissions and other expenses.

Short-term Liquidity and Capital Resources

For at least the next twelve months, we expect our principal demand for funds will be for our ongoing activities described above. We expect to meet our short-term liquidity requirements primarily through our cash, cash equivalents and marketable securities on hand. We believe we will have sufficient liquidity available to fund our business needs, commitments and contractual obligations for the next twelve months.

Long-term Liquidity and Capital Resources

Beyond the next twelve months, our principal demand for funds will be to sustain our operations, including the construction of additional motherships under an agreement with a third-party contractor, and spaceship vehicles, construction of our astronaut campus, expansion of the New Mexico Spaceport, and for the payment of the principal amount of our convertible senior notes as it becomes due. We expect to begin generating revenue from our human spaceflight program, which is expected to launch in the second quarter of 2023. To the extent this source of capital as well as the sources of capital described above are insufficient to meet our needs, we may also conduct additional offerings of our securities or refinance debt. We expect these resources will be adequate to fund our ongoing operating activities.

The commercial launch of our human spaceflight program and the anticipated expansion of our fleet have unpredictable costs and are subject to significant risks, uncertainties and contingencies, many of which are beyond our control, that may affect the timing and magnitude of these anticipated expenditures. Some of these risk and uncertainties are described in more detail in our Annual Report on Form 10-K under the heading Item 1A. “Risk Factors—Risks Related to Our Business.”

Contractual Obligations and Commitments

Except as set forth in the notes to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, there have been no material changes outside the ordinary course of business to our contractual obligations and commitments as described in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K. Additionally, in some cases, we have entered arrangements with third-party providers for services, such as the design and manufacture of our next generation of carrier aircraft. The amounts we would pay under those arrangements will be significant but are not contractually committed until we execute specific task orders with the applicable counterparty, are subject to future negotiations and cannot be estimated with reasonable certainty.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of our condensed consolidated financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures. We believe that the estimates, assumptions and judgments involved in the accounting policies described below have the greatest potential impact on our financial statements and, therefore, we consider these to be our critical accounting policies. Accordingly, we evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions.

During the fiscal quarter ended March 31, 2023, there were no significant changes to our critical accounting policies and estimates compared to those previously disclosed in "Critical Accounting Policies and Estimates" included in Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our 2022 Annual Report on Form 10-K.

Market risk

As filed, 270 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

During the fiscal quarter ended March 31, 2023, there were no significant changes to our markets risks compared to those previously disclosed in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk included in our 2022 Annual Report on Form 10-K.

Controls and procedures

As filed, 1,438 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2023, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the three months ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 963 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our business, financial condition and operating results can be affected by a number of factors, whether currently known or unknown, including but not limited to those described as risk factors, any one or more of which could, directly or indirectly, cause our actual operating results and financial condition to vary materially from past, or anticipated future, operating results and financial condition. For a discussion of our potential risks and uncertainties, see the risk factors previously disclosed in Part I, Item 1. “Business,” Part I, Item 1A. “Risk Factors,” and Part II, Item 7. “Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K and in Part I, Item 2. “Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Quarterly Report on Form 10-Q. There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-01-01 to 2023-03-31$392.0kus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2023-01-01 to 2023-03-31$318.0kus-gaap:CostOfRevenue
Research and development3 months2023-01-01 to 2023-03-31$109.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2023-01-01 to 2023-03-31$50.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-01-01 to 2023-03-31−$163.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2023-01-01 to 2023-03-31$3.2mus-gaap:InterestExpense
Income tax3 months2023-01-01 to 2023-03-31$128.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-01-01 to 2023-03-31−$159.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-01-01 to 2023-03-31−$0.57us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-01-01 to 2023-03-31−$0.57us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-01-01 to 2023-03-31278,450,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2023-01-01 to 2023-03-31−$136.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2023-01-01 to 2023-03-31$2.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2023-03-31$415.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-03-31$919.8mus-gaap:AssetsCurrent
Total assetsAt period end2023-03-31$1.03bnus-gaap:Assets
Current liabilitiesAt period end2023-03-31$190.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-03-31$666.7mus-gaap:Liabilities
Shareholders' equityAt period end2023-03-31$366.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001706946-23-000032. Last ingested by Listed: Nov 14, 2026, 11:33 ET. Listed shows no prices and gives no investment advice.